Skip to main content

Table 1 The CCT2 and PDIA3 expression and clinicopathological features of gallbladder SC/ASC and AC

From: Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma

Clinicalpathological features SC/ASC (n = 46) AC (n = 80) χ2 P
Gender     
male 19(41.3) 26(32.5) 0.986 0.352
female 27(58.7) 54(67.5)
Age (years)     
≤ 45 3(6.5) 16(20.0) 4.143 0.042
> 45 43(93.5) 64(80.0)
Degree of differentiation     
well-differentiated 16(34.8) 27(33.8) 8.515 0.014
moderately-Differentiated 24(52.2) 25(31.3)
poorly-differentiated 6(13.0) 28(35.0)
Tumor maximum diameter (cm)     
≤ 3 cm 20(43.5) 50(62.5) 4.280 0.039
> 3 cm 26(56.5) 30(37.5)   
Gallbladder stones     
no 18(39.1) 42(52.5) 2.093 0.148
yes 28(60.9) 38(47.5)
TNM stage     
I+II 12(26.1) 21(26.3) 0.287 0.866
III 20(33.5) 38(47.5)
IV 14(30.4) 21(26.3)
Lymph node metastasis     
no 17(37.0) 30(37.5) 0.004 0.952
yes 29(63.0) 50(62.5)   
Invasion     
no 16(34.8) 31(38.8) 0.197 0.658
yes 30(62.5) 49(61.3)
Surgical     
radical 14(30.4) 26(32.5) 0.215 0.898
palliative 18(39.1) 28(35.0)
biopsy 14(30.4) 26(32.5)
average survival time 10.07(4 to 25) 10.34(3 to 27) 0.014 0.906
CCT2     
- 23(50.0) 31(46.2) 0.165 0.685
+ 23(50.0) 49(53.8)   
PDIA3     
- 20(43.5) 35(43.7) 0.001 0.976
+ 26(56.5) 45(56.3)